Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

PHASE2CompletedINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

75 mg LX4211

Subjects will receive 75 mg LX4211 once daily

DRUG

200 mg LX4211

Subjects will receive 200 mg LX4211 once daily.

DRUG

400 mg LX4211

Subjects will receive 400 mg LX4211 once daily.

DRUG

200 mg LX4211

Subjects will receive 200 mg LX4211 twice daily.

DRUG

Placebo

Subjects will receive placebo once daily.

Trial Locations (56)

11023

Lexicon Investigational Site, Great Neck

14224

Lexicon Investigational Site, West Seneca

15401

Lexicon Investigational Site, Uniontown

19713

Lexicon Investigational Site, Newark

23454

Lexicon Investigational Site, Virginia Beach

27103

Lexicon Investigational Site, Winston-Salem

27455

Lexicon Investigational Site, Greensboro

29325

Lexicon Investigational Site, Clinton

29464

Lexicon Investigational Site, Mt. Pleasant

30513

Lexicon Investigational Site, Blue Ridge

31406

Lexicon Investigational Site, Savannah

32132

Lexicon Investigational Site, Edgewater

32792

Lexicon Investigational Site, Winter Park

32806

Lexicon Investigational Site, Orlando

33135

Lexicon Investigational Site, Miami

33401

Lexicon Investigational Site, West Palm Beach

37411

Lexicon Investigational Site, Chattanooga

37421

Lexicon Investigational Site, Chattanooga

38654

Lexicon Investigational Site, Olive Branch

42431

Lexicon Investigational Site, Madisonville

43551

Lexicon Investigational Site, Perrysburg

44614

Lexicon Investigational Site, Canal Fulton

45429

Lexicon Investigational Site, Kettering

45439

Lexicon Investigational Site, Dayton

47904

Lexicon Investigational Site, Lafayette

49684

Lexicon Investigational Site, Traverse City

58201

Lexicon Investigational Site, Grand Forks

64111

Lexicon Investigational Site, Kansas City

68131

Lexicon Investigational Site, Omaha

70808

Lexicon Investigational Site, Baton Rouge

75230

Lexicon Investigational Site, Dallas

76543

Lexicon Investigational Site, Killeen

77024

Lexicon Investigational Site, Houston

77098

Lexicon Investigational Site, Houston

77375

Lexicon Investigational Site, Tomball

78229

Lexicon Investigational Site, San Antonio

78258

Lexicon Investigational Site, San Antonio

78728

Lexicon Investigational Site, Austin

80209

Lexicon Investigational Site, Denver

80220

Lexicon Investigational Site, Denver

84109

Lexicon Investigational Site, Salt Lake City

84403

Lexicon Investigational Site, Ogden

89101

Lexicon Investigational Site, Las Vegas

89128

Lexicon Investigational Site, Las Vegas

91325

Lexicon Investigational Site, Northridge

91356

Lexicon Investigational Site, Tarzana

92037

Lexicon Investigational Site, La Jolla

92780

Lexicon Investigational Site, Tustin

92801

Lexicon Investigational Site, Anaheim

92868

Lexicon Investigational Site, Orange

93449

Lexicon Investigational Site, Pismo Beach

94904

Lexicon Investigational Site, Greenbrae

95608

Lexicon Investigational Site, Carmichael

97404

Lexicon Investigational Site, Eugene

02301

Lexicon Investigational Site, Brockton

02453

Lexicon Investigational Site, Waltham

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY